Search research articles
Contact Us
Filters
Showing results (211-220 of 258) with videos related to
Page
of 26
Sort By:
Cancer Immunology Research
|
June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
Todd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.
Nature Medicine
|
February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros, Maria R Parkhurst, Eric Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1
Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.
Cancer Immunology, Immunotherapy : CII
|
December 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers
S M Rafiqul Islam, Samantha Seitter, Maria Parkhurst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2018
T-cell Responses to <i>TP53</i> "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
Drew C Deniger, Anna Pasetto, Paul F Robbins, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer
Nachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
The Journal of Investigative Dermatology
|
November 26, 2013
Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology
Zoltan Pos, Tara L Spivey, Hui Liu, et al.
The Journal of Clinical Investigation
|
March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors
Alena Gros, Paul F Robbins, Xin Yao, et al.
The Journal of Clinical Investigation
|
February 5, 2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Parisa Malekzadeh, Anna Pasetto, Paul F Robbins, et al.
The Journal of Clinical Investigation
|
September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 258) with videos related to
Sort By:
Page
of 26
Cancer Immunology Research
|
June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
Todd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.
Nature Medicine
|
February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros, Maria R Parkhurst, Eric Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1
Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.
Cancer Immunology, Immunotherapy : CII
|
December 18, 2025
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers
S M Rafiqul Islam, Samantha Seitter, Maria Parkhurst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2018
T-cell Responses to <i>TP53</i> "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
Drew C Deniger, Anna Pasetto, Paul F Robbins, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer
Nachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
The Journal of Investigative Dermatology
|
November 26, 2013
Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology
Zoltan Pos, Tara L Spivey, Hui Liu, et al.
The Journal of Clinical Investigation
|
March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors
Alena Gros, Paul F Robbins, Xin Yao, et al.
The Journal of Clinical Investigation
|
February 5, 2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
Parisa Malekzadeh, Anna Pasetto, Paul F Robbins, et al.
The Journal of Clinical Investigation
|
September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.
Page
of 26